EC Number |
Application |
Reference |
---|
2.1.1.20 | diagnostics |
enzyme level suitable as prognostic marker for human cholangiocarcinoma and hepatocellular carcinoma |
688121 |
2.1.1.20 | diagnostics |
partially suitable to distinguish between benign and malign tumor forms |
673122 |
2.1.1.20 | medicine |
activation and induction of enzyme by retinoids are tissue- and gender-specific |
485232 |
2.1.1.20 | medicine |
all-trans-retinoic acid and dexamethasone independently induce GNMT in liver, thereby having substantial implications for the potential interaction of retinoic administration with diabetes |
659768 |
2.1.1.20 | medicine |
diabetes increases the activity and abundance of GNMT, lack of dietary folate results in the highest activity of GNMT in diabetic rats without the abundance of the protein being altered |
671233 |
2.1.1.20 | medicine |
feeding with excess methionine leads to upregulation of hepatic enzyme |
485229 |
2.1.1.20 | medicine |
glycine N-methyltransferase is a tumor susceptibility gene for both hepatocellular carcinoma and prostate cancer |
703849 |
2.1.1.20 | medicine |
GNMT 1289 C->T polymorphism influences plasma homocysteine and is responsive to folate intake, plasma homocysteine concentrations do not differ among the GNMT C1289T genotypes at baseline. After folate restriction, women with the GNMT 1289 TT genotype have higher homocysteine concentrations than women with the CT or CC genotype. The influence of the GNMT 1289 C->T variant on homocysteine is dependent on the MTHFR C677T genotype. In subjects with the MTHFR 677 CC genotype, homocysteine is greater for GNMT 1289 TT subjects relative to 1289 CT or CC subjects. In subjects with the MTHFR 677 TT genotype, plasma homocysteine concentrations do not differ among the GNMT C1289T genotypes |
675559 |
2.1.1.20 | medicine |
GNMT is a tumor suppressor gene for liver cancer, and is associated with gender disparity in liver cancer susceptibility |
704068 |
2.1.1.20 | medicine |
GNMT is a tumor susceptibility gene for prostate cancer, three major GNMT haplotypes in our populations, haplotype C conferred protection from the development of prostate cancer and exhibits the highest promoter activity |
673122 |